David Zaccardelli | President and Chief Executive Officer |
Mark Hahn | Chief Financial Officer |
Kathleen Rickard | Chief Medical Officer |
Christopher Martin | Senior Vice President Commercial |
Andreas Argyrides | Wedbush |
Joon Lee | Truist Securities |
Thomas Shrader | BTIG |
Boobalan Pachaiyappan | H.C. Wainwright |
Welcome to Verona Pharma's, Fourth Quarter and Full Year 2022 Financial Results and Operating Highlights Conference Call. At this time all participants are in a listen-only mode.
Earlier this morning Verona Pharma issued a press release announcing its financial results for the three months and full year ended December 31, 2022. A copy can be found in the Investor Relations tab on the corporate website, www.veronapharma.com.
Before we begin, I'd like to remind you that during today's call, statements about the company's future expectations, plans and prospects are forward-looking statements.